Description:
Memantine is the first in a novel class of Alzheimer's disease medications acting on the glutamatergic system by blocking NMDA receptors.It is also a CYP2B6 and CYP2D6 inhibitor for recombinant CYP2B6 and CYP2D6 with Ki of 0.51 nM and 94.9 μM, respectively.
- Molecular Weight:215.76
- Melting Point:>300°C (sublimes)
- Purity:>98%
Molecular Formula:
C12H21N.HCl
Canonical SMILES:
CC12CC3CC(C1)(CC(C3)(C2)N)C.Cl
InChI:
InChI=1S/C12H21N.ClH/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10;/h9H,3-8,13H2,1-2H3;1H
InChIKey:
LDDHMLJTFXJGPI-UHFFFAOYSA-N
Solubility:
29.4 [ug/mL] (The mean of the results at pH 7.4)
Appearance:
White crystalline powder
Application:
Antiparkinson Agents
Synonyms:
3,5-Dimethyltricyclo[3.3.1.13,7]decan-1-amine Hydrochloride; 3,5-Dimethyl-1- adamantanamine; 1-Amino-3,5-dimethyladamantane Hydrochloride; Akatinol; Axura; Ebix; Ebixia; Ebixza; NSC 102290; Namenda; SUN Y7017; Tocris Más detalles se encuentran
aquí